{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:18Z","timestamp":1786980258952,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["432980"],"award-info":[{"award-number":["432980"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NephCure Kidney International"},{"DOI":"10.13039\/100009268","name":"Alport Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00467-021-04934-y","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T09:03:07Z","timestamp":1614330187000},"page":"253-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Population-based studies reveal an additive role of type IV collagen variants in hematuria and albuminuria"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-9071","authenticated-orcid":false,"given":"Moumita","family":"Barua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-118X","authenticated-orcid":false,"given":"Andrew D.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"4934_CR1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K, Nozu K, Renieri A, Rheault M, Wang F, Gross O (2018) Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int 93:1045\u20131051","journal-title":"Kidney Int"},{"key":"4934_CR2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","volume":"58","author":"M Levy","year":"2000","unstructured":"Levy M, Feingold J (2000) Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 58:925\u2013943","journal-title":"Kidney Int"},{"key":"4934_CR3","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1113\/jphysiol.2014.274449","volume":"592","author":"J Savige","year":"2014","unstructured":"Savige J (2014) Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol 592:4013\u20134023","journal-title":"J Physiol"},{"key":"4934_CR4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2014.229","volume":"86","author":"JH Miner","year":"2014","unstructured":"Miner JH, Baigent C, Flinter F, Gross O, Judge P, Kashtan CE, Lagas S, Savige J, Blatt D, Ding J, Gale DP, Midgley JP, Povey S, Prunotto M, Renault D, Skelding J, Turner AN, Gear S (2014) The 2014 International Workshop on Alport Syndrome. Kidney Int 86:679\u2013684","journal-title":"Kidney Int"},{"key":"4934_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1523-1755.2004.00390.x","volume":"65","author":"H Izzedine","year":"2004","unstructured":"Izzedine H, Tankere F, Launay-Vacher V, Deray G (2004) Ear and kidney syndromes: molecular versus clinical approach. Kidney Int 65:369\u2013385","journal-title":"Kidney Int"},{"key":"4934_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/ajkd.2002.31997","volume":"39","author":"MC Byrne","year":"2002","unstructured":"Byrne MC, Budisavljevic MN, Fan Z, Self SE, Ploth DW (2002) Renal transplant in patients with Alport\u2019s syndrome. Am J Kidney Dis 39:769\u2013775","journal-title":"Am J Kidney Dis"},{"key":"4934_CR7","first-page":"163","volume":"13","author":"D Perrin","year":"1980","unstructured":"Perrin D, Jungers P, Grunfeld JP, Delons S, Noel LH, Zenatti C (1980) Perimacular changes in Alport\u2019s syndrome. Clin Nephrol 13:163\u2013167","journal-title":"Clin Nephrol"},{"key":"4934_CR8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/13816811003767128","volume":"31","author":"SN Shah","year":"2010","unstructured":"Shah SN, Weinberg DV (2010) Giant macular hole in Alport syndrome. Ophthalmic Genet 31:94\u201397","journal-title":"Ophthalmic Genet"},{"key":"4934_CR9","first-page":"1241","volume":"35","author":"SJ Hasstedt","year":"1983","unstructured":"Hasstedt SJ, Atkin CL (1983) X-linked inheritance of Alport syndrome: family P revisited. Am J Hum Genet 35:1241\u20131251","journal-title":"Am J Hum Genet"},{"key":"4934_CR10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ki.1996.459","volume":"50","author":"CE Kashtan","year":"1996","unstructured":"Kashtan CE, Michael AF (1996) Alport syndrome. Kidney Int 50:1445\u20131463","journal-title":"Kidney Int"},{"key":"4934_CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.V75702","volume":"7","author":"N Heiskari","year":"1996","unstructured":"Heiskari N, Zhang X, Zhou J, Leinonen A, Barker D, Gregory M, Atkin CL, Netzer KO, Weber M, Reeders S, Gronhagen-Riska C, Neumann HP, Trembath R, Tryggvason K (1996) Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome. J Am Soc Nephrol 7:702\u2013709","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ki.1993.8","volume":"43","author":"K Tryggvason","year":"1993","unstructured":"Tryggvason K, Zhou J, Hostikka SL, Shows TB (1993) Molecular genetics of Alport syndrome. Kidney Int 43:38\u201344","journal-title":"Kidney Int"},{"key":"4934_CR13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan CE (1998) Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 9:1736\u20131750","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR14","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen. N Engl J Med 348:2543\u20132556","journal-title":"N Engl J Med"},{"key":"4934_CR15","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/ndt\/gfh435","volume":"19","author":"R Torra","year":"2004","unstructured":"Torra R, Tazon-Vega B, Ars E, Ballarin J (2004) Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. Nephrol Dial Transplant 19:2429\u20132432","journal-title":"Nephrol Dial Transplant"},{"key":"4934_CR16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.2349482","volume":"248","author":"DF Barker","year":"1990","unstructured":"Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224\u20131227","journal-title":"Science"},{"key":"4934_CR17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI117073","volume":"93","author":"C Antignac","year":"1994","unstructured":"Antignac C, Knebelmann B, Drouot L, Gros F, Deschenes G, Hors-Cayla MC, Zhou J, Tryggvason K, Grunfeld JP, Broyer M (1994) Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. J Clin Invest 93:1195\u20131207","journal-title":"J Clin Invest"},{"key":"4934_CR18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cge.12258","volume":"86","author":"C Fallerini","year":"2014","unstructured":"Fallerini C, Dosa L, Tita R, Del Prete D, Feriozzi S, Gai G, Clementi M, La Manna A, Miglietti N, Mancini R, Mandrile G, Ghiggeri GM, Piaggio G, Brancati F, Diano L, Frate E, Pinciaroli AR, Giani M, Castorina P, Bresin E, Giachino D, De Marchi M, Mari F, Bruttini M, Renieri A, Ariani F (2014) Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet 86:252\u2013257","journal-title":"Clin Genet"},{"key":"4934_CR19","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1681\/ASN.2013080912","volume":"25","author":"V Moriniere","year":"2014","unstructured":"Moriniere V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, Bole-Feysot C, Pruvost S, Nitschke P, Plaisier E, Knebelmann B, Macher MA, Noel LH, Gubler MC, Antignac C, Heidet L (2014) Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 25:2740\u20132751","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR20","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2000.00358.x","volume":"58","author":"FT van der Loop","year":"2000","unstructured":"van der Loop FT, Heidet L, Timmer ED, van den Bosch BJ, Leinonen A, Antignac C, Jefferson JA, Maxwell AP, Monnens LA, Schroder CH, Smeets HJ (2000) Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 58:1870\u20131875","journal-title":"Kidney Int"},{"key":"4934_CR21","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00379.x","volume":"61","author":"I Longo","year":"2002","unstructured":"Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frasca G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, De Marchi M (2002) COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 61:1947\u20131956","journal-title":"Kidney Int"},{"key":"4934_CR22","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1523-1755.2004.00560.x","volume":"65","author":"C Pescucci","year":"2004","unstructured":"Pescucci C, Mari F, Longo I, Vogiatzi P, Caselli R, Scala E, Abaterusso C, Gusmano R, Seri M, Miglietti N, Bresin E, Renieri A (2004) Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 65:1598\u20131603","journal-title":"Kidney Int"},{"key":"4934_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jmedgenet-2014-102822","volume":"52","author":"MA Mencarelli","year":"2015","unstructured":"Mencarelli MA, Heidet L, Storey H, van Geel M, Knebelmann B, Fallerini C, Miglietti N, Antonucci MF, Cetta F, Sayer JA, van den Wijngaard A, Yau S, Mari F, Bruttini M, Ariani F, Dahan K, Smeets B, Antignac C, Flinter F, Renieri A (2015) Evidence of digenic inheritance in Alport syndrome. J Med Genet 52:163\u2013174","journal-title":"J Med Genet"},{"key":"4934_CR24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2000) X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649\u2013657","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia MR, Reed B, Gregory MC, McFann K, Shamshirsaz AA, Masoumi A, Schrier RW (2010) Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol 21:876\u2013883","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR26","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schroder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol 14:2603\u20132610","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/ndt\/gfp551","volume":"25","author":"MN Rheault","year":"2010","unstructured":"Rheault MN, Kren SM, Hartich LA, Wall M, Thomas W, Mesa HA, Avner P, Lees GE, Kashtan CE, Segal Y (2010) X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome. Nephrol Dial Transplant 25:764\u2013769","journal-title":"Nephrol Dial Transplant"},{"key":"4934_CR28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1681\/ASN.V981433","volume":"9","author":"K Nakanishi","year":"1998","unstructured":"Nakanishi K, Iijima K, Kuroda N, Inoue Y, Sado Y, Nakamura H, Yoshikawa N (1998) Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome. J Am Soc Nephrol 9:1433\u20131440","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/jmg.29.9.663","volume":"29","author":"D Vetrie","year":"1992","unstructured":"Vetrie D, Flinter F, Bobrow M, Harris A (1992) X inactivation patterns in females with Alport\u2019s syndrome: a means of selecting against a deleterious gene? J Med Genet 29:663\u2013666","journal-title":"J Med Genet"},{"key":"4934_CR30","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood.V83.10.2899.2899","volume":"83","author":"RE Gale","year":"1994","unstructured":"Gale RE, Wheadon H, Boulos P, Linch DC (1994) Tissue specificity of X-chromosome inactivation patterns. Blood 83:2899\u20132905","journal-title":"Blood"},{"key":"4934_CR31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","volume":"550","author":"T Tukiainen","year":"2017","unstructured":"Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, Cummings BB, Castel SE, Karczewski KJ, Aguet F, Byrnes A, GTEx Consortium; Laboratory, Data Analysis &Coordinating Center (LDACC)\u2014Analysis Working Group; Statistical Methods groups\u2014Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Common Fund; NIH\/NCI; NIH\/NHGRI; NIH\/NIMH; NIH\/NIDA; Biospecimen Collection Source Site\u2014NDRI; Biospecimen Collection Source Site\u2014RPCI; Biospecimen Core Resource\u2014VARI; Brain Bank Repository\u2014University of Miami Brain Endowment Bank; Leidos Biomedical\u2014Project Management; ELSI Study; Genome Browser Data Integration &Visualization\u2014EBI; Genome Browser Data Integration &Visualization\u2014UCSC Genomics Institute, University of California Santa Cruz, Lappalainen T, Regev A, Ardlie KG, Hacohen N, MacArthur DG (2017) Landscape of X chromosome inactivation across human tissues. Nature 550:244\u2013248","journal-title":"Nature"},{"key":"4934_CR32","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/hmg\/3.8.1269","volume":"3","author":"HH Lemmink","year":"1994","unstructured":"Lemmink HH, Mochizuki T, van den Heuvel LP, Schroder CH, Barrientos A, Monnens LA, van Oost BA, Brunner HG, Reeders ST, Smeets HJ (1994) Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3:1269\u20131273","journal-title":"Hum Mol Genet"},{"key":"4934_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng0994-77","volume":"8","author":"T Mochizuki","year":"1994","unstructured":"Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroder CH, Smeets HJ, Reeders ST (1994) Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77\u201381","journal-title":"Nat Genet"},{"key":"4934_CR34","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1681\/ASN.2012100985","volume":"24","author":"H Storey","year":"2013","unstructured":"Storey H, Savige J, Sivakumar V, Abbs S, Flinter FA (2013) COL4A3\/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. J Am Soc Nephrol 24:1945\u20131954","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00467-014-2797-4","volume":"29","author":"M Oka","year":"2014","unstructured":"Oka M, Nozu K, Kaito H, Fu XJ, Nakanishi K, Hashimura Y, Morisada N, Yan K, Matsuo M, Yoshikawa N, Vorechovsky I, Iijima K (2014) Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol 29:1535\u20131544","journal-title":"Pediatr Nephrol"},{"key":"4934_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.V12197","volume":"12","author":"L Heidet","year":"2001","unstructured":"Heidet L, Arrondel C, Forestier L, Cohen-Solal L, Mollet G, Gutierrez B, Stavrou C, Gubler MC, Antignac C (2001) Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 12:97\u2013106","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ndt\/gfi312","volume":"21","author":"I Longo","year":"2006","unstructured":"Longo I, Scala E, Mari F, Caselli R, Pescucci C, Mencarelli MA, Speciale C, Giani M, Bresin E, Caringella DA, Borochowitz ZU, Siriwardena K, Winship I, Renieri A, Meloni I (2006) Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families. Nephrol Dial Transplant 21:665\u2013671","journal-title":"Nephrol Dial Transplant"},{"key":"4934_CR38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","volume":"81","author":"J Temme","year":"2012","unstructured":"Temme J, Peters F, Lange K, Pirson Y, Heidet L, Torra R, Grunfeld JP, Weber M, Licht C, Muller GA, Gross O (2012) Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations. Kidney Int 81:779\u2013783","journal-title":"Kidney Int"},{"key":"4934_CR39","first-page":"1016","volume":"4","author":"JM Pochet","year":"1989","unstructured":"Pochet JM, Bobrie G, Landais P, Goldfarb B, Grunfeld JP (1989) Renal prognosis in Alport\u2019s and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant 4:1016\u20131021","journal-title":"Nephrol Dial Transplant"},{"key":"4934_CR40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1076\/1381-6810(200012)2141-HFT217","volume":"21","author":"D Colville","year":"2000","unstructured":"Colville D, Wang YY, Jamieson R, Collins F, Hood J, Savige J (2000) Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties. Ophthalmic Genet 21:217\u2013225","journal-title":"Ophthalmic Genet"},{"key":"4934_CR41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000368519","volume":"40","author":"C Rosado","year":"2015","unstructured":"Rosado C, Bueno E, Felipe C, Valverde S, Gonzalez-Sarmiento R (2015) Study of the true clinical progression of autosomal dominant Alport syndrome in a European population. Kidney Blood Press Res 40:435\u2013442","journal-title":"Kidney Blood Press Res"},{"key":"4934_CR42","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddy409","volume":"28","author":"S Benonisdottir","year":"2019","unstructured":"Benonisdottir S, Kristjansson RP, Oddsson A, Steinthorsdottir V, Mikaelsdottir E, Kehr B, Jensson BO, Arnadottir GA, Sulem G, Sveinbjornsson G, Kristmundsdottir S, Ivarsdottir EV, Tragante V, Gunnarsson B, Runolfsdottir HL, Arthur JG, Deaton AM, Eyjolfsson GI, Davidsson OB, Asselbergs FW, Hreidarsson AB, Rafnar T, Thorleifsson G, Edvardsson V, Sigurdsson G, Helgadottir A, Halldorsson BV, Masson G, Holm H, Onundarson PT, Indridason OS, Benediktsson R, Palsson R, Gudbjartsson DF, Olafsson I, Thorsteinsdottir U, Sulem P, Stefansson K (2019) Sequence variants associating with urinary biomarkers. Hum Mol Genet 28:1199\u20131211","journal-title":"Hum Mol Genet"},{"key":"4934_CR43","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1681\/ASN.2019030218","volume":"30","author":"RM Salem","year":"2019","unstructured":"Salem RM, Todd JN, Sandholm N, Cole JB, Chen WM, Andrews D, Pezzolesi MG, McKeigue PM, Hiraki LT, Qiu C, Nair V, Di Liao C, Cao JJ, Valo E, Onengut-Gumuscu S, Smiles AM, McGurnaghan SJ, Haukka JK, Harjutsalo V, Brennan EP, van Zuydam N, Ahlqvist E, Doyle R, Ahluwalia TS, Lajer M, Hughes MF, Park J, Skupien J, Spiliopoulou A, Liu A, Menon R, Boustany-Kari CM, Kang HM, Nelson RG, Klein R, Klein BE, Lee KE, Gao X, Mauer M, Maestroni S, Caramori ML, de Boer IH, Miller RG, Guo J, Boright AP, Tregouet D, Gyorgy B, Snell-Bergeon JK, Maahs DM, Bull SB, Canty AJ, Palmer CNA, Stechemesser L, Paulweber B, Weitgasser R, Sokolovska J, Rovite V, Pirags V, Prakapiene E, Radzeviciene L, Verkauskiene R, Panduru NM, Groop LC, McCarthy MI, Gu HF, Mollsten A, Falhammar H, Brismar K, Martin F, Rossing P, Costacou T, Zerbini G, Marre M, Hadjadj S, McKnight AJ, Forsblom C, McKay G, Godson C, Maxwell AP, Kretzler M, Susztak K, Colhoun HM, Krolewski A, Paterson AD, Groop PH, Rich SS, Hirschhorn JN, Florez JC, SUMMIT Consortium, DCCT\/EDIC Research Group, GENIE Consortium (2019) Genome-wide association study of diabetic kidney disease highlights biology involved in glomerular basement membrane collagen. J Am Soc Nephrol 30:2000\u20132016. https:\/\/doi.org\/10.1681\/ASN.2019030218","journal-title":"J Am Soc Nephrol"},{"key":"4934_CR44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ajhg.2018.08.004","volume":"103","author":"ME Haas","year":"2018","unstructured":"Haas ME, Aragam KG, Emdin CA, Bick AG, International Consortium for Blood P, Hemani G, Davey Smith G, Kathiresan S (2018) Genetic association of albuminuria with cardiometabolic disease and blood pressure. Am J Hum Genet 103:461\u2013473","journal-title":"Am J Hum Genet"},{"key":"4934_CR45","doi-asserted-by":"publisher","unstructured":"Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars NJ, Aguirre M, Venkataraman GR, Wainberg M, Ollila HM, Pirruccello JP, Qian J, Shcherbina A, FinnGen, Rodriguez F, Assimes TL, Agarwala V, Tibshirani R, Hastie T, Ripatti S, Pritchard JK, Daly J, Rivas MA (2019) Genetics of 38 blood and urine biomarkers in the UK Biobank. bioRxiv preprint. https:\/\/doi.org\/10.1101\/660506","DOI":"10.1101\/660506"},{"key":"4934_CR46","doi-asserted-by":"publisher","unstructured":"Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, Gagliano Taliun SA, et al. (2019) Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. bioRxiv preprint. https:\/\/doi.org\/10.1101\/563866","DOI":"10.1101\/563866"},{"key":"4934_CR47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O\u2019Connell J, Cortes A, Welsh S, Young A, Effingham M, McVean G, Leslie S, Allen N, Donnelly P, Marchini J (2018) The UK Biobank resource with deep phenotyping and genomic data. Nature 562:203\u2013209","journal-title":"Nature"},{"key":"4934_CR48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/humu.9065","volume":"20","author":"H Dagher","year":"2002","unstructured":"Dagher H, Yan Wang Y, Fassett R, Savige J (2002) Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome. Hum Mutat 20:321\u2013322","journal-title":"Hum Mutat"},{"key":"4934_CR49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfv325","volume":"31","author":"C Gast","year":"2016","unstructured":"Gast C, Pengelly RJ, Lyon M, Bunyan DJ, Seaby EG, Graham N, Venkat-Raman G, Ennis S (2016) Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant 31:961\u2013970","journal-title":"Nephrol Dial Transplant"},{"key":"4934_CR50","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ki.2014.305","volume":"86","author":"AF Malone","year":"2014","unstructured":"Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA (2014) Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86:1253\u20131259","journal-title":"Kidney Int"},{"key":"4934_CR51","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.kint.2018.12.017","volume":"95","author":"D Zanetti","year":"2019","unstructured":"Zanetti D, Rao A, Gustafsson S, Assimes TL, Montgomery SB, Ingelsson E (2019) Identification of 22 novel loci associated with urinary biomarkers of albumin, sodium, and potassium excretion. Kidney Int 95:1197\u20131208","journal-title":"Kidney Int"},{"key":"4934_CR52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fgene.2019.00034","volume":"10","author":"H Schurz","year":"2019","unstructured":"Schurz H, Muller SJ, van Helden PD, Tromp G, Hoal EG, Kinnear CJ, Moller M (2019) Evaluating the accuracy of imputation methods in a five-way admixed population. Front Genet 10:34","journal-title":"Front Genet"},{"key":"4934_CR53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajhg.2018.12.015","volume":"104","author":"CF Wright","year":"2019","unstructured":"Wright CF, West B, Tuke M, Jones SE, Patel K, Laver TW, Beaumont RN, Tyrrell J, Wood AR, Frayling TM, Hattersley AT, Weedon MN (2019) Assessing the pathogenicity, penetrance, and expressivity of putative disease-causing variants in a population setting. Am J Hum Genet 104:275\u2013286","journal-title":"Am J Hum Genet"},{"key":"4934_CR54","doi-asserted-by":"crossref","first-page":"e76360","DOI":"10.1371\/journal.pone.0076360","volume":"8","author":"R Chatterjee","year":"2013","unstructured":"Chatterjee R, Hoffman M, Cliften P, Seshan S, Liapis H, Jain S (2013) Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria. PLoS One 8:e76360","journal-title":"PLoS One"},{"key":"4934_CR55","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbrc.2004.02.168","volume":"316","author":"YF Wang","year":"2004","unstructured":"Wang YF, Ding J, Wang F, Bu DF (2004) Effect of glycine substitutions on alpha5(IV) chain structure and structure-phenotype correlations in Alport syndrome. Biochem Biophys Res Commun 316:1143\u20131149","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-04934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T06:33:52Z","timestamp":1643956432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-04934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4934"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-04934-y","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"1 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}